SKI Market

A+| A| A-|

Indian Indices

Sensex

75,415.35 231.99
( 0.31%)

Global Indices

Nasdaq

50,600.73 294.06
(0.58%)

Dow Jones

7,493.73 27.01
(0.36%)

Hang Seng

63,328.42 1,644.28
(2.67%)

Nikkei 225

10,474.02 30.55
(0.29%)

Forex

USD-INR

96.29 -0.42
(-0.43%)

EUR-INR

111.82 -0.44
(-0.39%)

GBP-INR

129.28 -0.40
(-0.31%)

JPY-INR

0.61 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Caplin Point Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524742

INE475E01026

269.7614245

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CAPLIPOINT

38.89

15420.87

EPS(TTM)

Face Value()

Div & Yield %

52.17

0.2

Back

stelis biopharma ltd

Gujarat Cotex standalone net profit declines 58.33% in the December 2025 quarter

Feb 10,2026

Net profit of Gujarat Cotex declined 58.33% to Rs 0.05 crore in the quarter ended December 2025 as against Rs 0.12 crore during the previous quarter ended December 2024. Sales rose 9.47% to Rs 7.63 crore in the quarter ended December 2025 as against Rs 6.97 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	7.63	6.97	9
OPM %	-1.44	1.87	-
PBDT	0.06	0.12	-50
PBT	0.06	0.12	-50
NP	0.05	0.12	-58

75,415.35 231.99 ( 0.31%)

50,600.73 294.06 (0.58%)

7,493.73 27.01 (0.36%)

63,328.42 1,644.28 (2.67%)

10,474.02 30.55 (0.29%)

96.29 -0.42 (-0.43%)

111.82 -0.44 (-0.39%)

129.28 -0.40 (-0.31%)

0.61 0.00 (-0.48%)